BioNTech sits at 57.9% held by insiders and major holders. Institutions hold just 20.1%, leaving the rest to everyone else. Only 43.5% of shares are actually free to trade, barely over 107 million of nearly 248 million. That insider stake towers over the median of 1.4% across this entire screened universe. Named officers and directors hold just 16%, so most of that stake sits elsewhere. Subscribe — we show the numbers, not the story.
Want a channel or video like this for your brand or business? Contact studio@mixinumhq.com.
The narration is AI-written from this episode's data and read by a synthetic text-to-speech voice. Not financial advice. Every number here is public — check it.
#BNTX #stocks #stockmarket
More
Mixinum Financial Review: https://www.dailymotion.com/mixinum
